Off label use—label off use?
Open Access
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 14 (1) , 1-5
- https://doi.org/10.1093/annonc/mdg035
Abstract
During the last century broad medical progress arose from the development of treatment strategies from natural remedies and the industrial production of drugs. Where there used to be a direct relationship between the natural healer or physician recommending an individualised treatment, the pharmacist preparing a custom-made prescription and the single patient, there is now a drugs market with the pharmaceutical industry on the supplier side, the patient as consumer and physicians who ideally prescribe drugs based on evidence and according to pertinent guidelines. The reproducibility and quality of diagnostic procedures as well as the drug supply have increased and the general benefit for society and individual patients is obvious. Cancer patients have benefited significantly from this process and the overall cure rate of >70% in paediatric malignancies would not have been achieved without cytostatic drugs developed and provided by the pharmaceutical industry.Keywords
This publication has 12 references indexed in Scilit:
- Unlicensed and off label drug use in acute lymphoblastic leukaemia and other malignancies in childrenAnnals of Oncology, 2003
- Off label prescribing to children in primary care in Germany: retrospective cohort studyBMJ, 2002
- Off-label and unlicensed use of antidotes in paediatric patientsEuropean Journal of Clinical Pharmacology, 2001
- Unlicensed and off label prescribing of drugs in general practiceArchives of Disease in Childhood, 2000
- Survey of unlicensed and off label drug use in paediatric wards in European countriesBMJ, 2000
- Off‐label prescribingJournal of Legal Medicine, 1999
- Unlicensed and off label drug use in neonates CommentaryArchives of Disease in Childhood: Fetal & Neonatal, 1999
- Changes at FDA May Speed Drug Approval Process and Increase Off-Label UseJNCI Journal of the National Cancer Institute, 1998
- Unlicensed and off label drug use in paediatric wards: prospective studyBMJ, 1998
- 'Off-label' use of prescription drugs: Legal, clinical and policy considerationsEuropean Journal of Anaesthesiology, 1997